how to get glp-1 drugs for weight loss medications are transforming diabetes and treatment Comparing Ozempic, Wegovy and Other

Now the situation is changing

Master protocols to study multiple therapies, multiple diseases, or both

Ozempic has proven behavioral changes related to eating such as decreased (or astonishingly zero) cravings for sugary foods and alcohol, and aversions to former favorite comfort foods or guilty pleasures

Tirzepatide at $400/month for 12 months ($4,800 total) producing 50 pounds of weight loss equals $96 per pound

However, and despite these limitations, SGLT-2 inhibitors or a GLP-1RA with proven CV disease benefit are recommended in patients with type 2 diabetes and CV disease, established kidney disease, or HF [7,8,9,10]

Two were approved for obesity while 8 were approved for Type 2 diabetes